Ascendis Pharma A/S vs Comcast Corporation — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.78B), while Comcast Corporation trades at $25.63 (market cap $89.43B). The key difference: Comcast Corporation is far larger — about 5.3× Ascendis Pharma A/S's market cap, and Comcast Corporation pays a 5.24% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | CMCSA | |
|---|---|---|
Market Cap | $16.78B | $89.43B |
Sector | Health | Media |
52-Week High | $277.18 | $32.50 |
52-Week Low | $189.74 | $21.92 |
Enterprise Value | $17.15B | $172.15B |
Dividend Yield | — | 5.24% |
Trailing returns across standard periods
Latest headlines on both assets
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Comcast is made up of three parts. The core cable business owns networks capable of providing television, internet access, and phone services to roughly 61 million U.S. homes and businesses, or nearly half of the country. About 56% of the homes in this territory subscribe to at least one Comcast service. Comcast acquired NBCUniversal from General Electric in 2011. NBCU owns several cable networks, including CNBC, MSNBC, and USA, the NBC broadcast network, several local NBC affiliates, Universal Studios, and several theme parks. Sky, acquired in 2018, is the dominant television provider in the U.K. and has invested heavily in exclusive and proprietary content to build this position. The firm is also the largest pay-television provider in Italy and has a presence in Germany and Austria.
Read more on CMCSA →